Comparative effectiveness and safety of rituximab versus subsequent anti–tumor necrosis factor therapy in patients with rheumatoid arthritis with prior exposure to anti–tumor necrosis factor therapies in the United States Corrona registry

被引：0
|
作者：
Leslie R. Harrold
George W. Reed
Robert Magner
Ashwini Shewade
Ani John
Jeffrey D. Greenberg
Joel M. Kremer
机构：
[1] University of Massachusetts Medical School,Department of Orthopedics
[2] Corrona,undefined
[3] LLC,undefined
[4] Genentech,undefined
[5] Inc,undefined
[6] New York University School of Medicine,undefined
[7] Albany Medical Center and The Center of Rheumatology,undefined
来源：
Arthritis Research & Therapy | / 17卷
关键词：
Rheumatoid Arthritis; Propensity Score; Biologic Agent; Clinical Disease Activity Index; Modify Health Assessment Questionnaire;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Comparative effectiveness and safety of rituximab versus subsequent anti-tumor necrosis factor therapy in patients with rheumatoid arthritis with prior exposure to anti-tumor necrosis factor therapies in the United States Corrona registry
    Harrold, Leslie R.
    Reed, George W.
    Magner, Robert
    Shewade, Ashwini
    John, Ani
    Greenberg, Jeffrey D.
    Kremer, Joel M.
    ARTHRITIS RESEARCH & THERAPY, 2015, 17
  • [2] COMPARATIVE EFFECTIVENESS OF RITUXIMAB VERSUS SUBSEQUENT ANTI-TUMOR NECROSIS FACTOR IN CUMULATIVE PREDNISONE EXPOSURE IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH PRIOR EXPOSURE TO TNFI
    Harrold, L.
    Reed, G.
    Magner, R.
    Shewade, A.
    John, A.
    Greenberg, J.
    Kremer, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 508 - 508
  • [3] Comparative Effectiveness of Abatacept Versus Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis Who Are Anti-CCP Positive in the United States Corrona Registry
    Leslie R. Harrold
    Heather J. Litman
    Sean E. Connolly
    Evo Alemao
    Sheila Kelly
    Sabrina Rebello
    Winnie Hua
    Joel M. Kremer
    Rheumatology and Therapy, 2019, 6 : 217 - 230
  • [4] Comparative Effectiveness of Abatacept Versus Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis Who Are Anti-CCP Positive in the United States Corrona Registry
    Harrold, Leslie R.
    Litman, Heather J.
    Connolly, Sean E.
    Alemao, Evo
    Kelly, Sheila
    Rebello, Sabrina
    Hua, Winnie
    Kremer, Joel M.
    RHEUMATOLOGY AND THERAPY, 2019, 6 (02) : 217 - 230
  • [5] COMPARATIVE EFFECTIVENESS OF RITUXIMAB VERSUS ANTI-TUMOR NECROSIS FACTOR SWITCHING FOR RHEUMATOID ARTHRITIS PATIENTS
    Harrold, L.
    Reed, G.
    Magner, R.
    Shewade, A.
    John, A.
    Reiss, W.
    Greenberg, J.
    Kremer, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 460 - 460
  • [6] Comparative Effectiveness Of Rituximab Vs. Subsequent Anti-Tumor Necrosis Factor In Patients With Rheumatoid Arthritis With Prior Exposure To TNFi.
    Harrold, Leslie R.
    Reed, George W.
    Magner, Robert P.
    Shewade, Ashwini
    John, Ani
    Greenberg, Jeffrey D.
    Kremer, Joel M.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S610 - S610
  • [7] Safety of Anti-Tumor Necrosis Factor Therapies in Arthritis Patients
    Nanau, Radu M.
    Neuman, Manuela G.
    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2014, 17 (03): : 324 - 361
  • [8] Comparative Effectiveness of Tocilizumab Monotherapy with Tumor Necrosis Factor Inhibitors in Combination with Methotrexate in Patients with Rheumatoid Arthritis and Prior Exposure to Tumor Necrosis Factor Inhibitors
    Harrold, Leslie R.
    Reed, George W.
    Best, Jennie
    Zlotnick, Steve
    Persuitte, Gioia
    Kremer, Joel M.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [9] Persistence with Anti-Tumor Necrosis Factor Therapies in Patients with Rheumatoid Arthritis: Observations from the RADIUS Registry
    Markenson, Joseph A.
    Gibofsky, Allan
    Palmer, William R.
    Keystone, Edward C.
    Schiff, Michael H.
    Feng, Jingyuan
    Baumgartner, Scott W.
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (07) : 1273 - 1281
  • [10] The comparative effectiveness of methotrexate and anti-tumor necrosis factor therapy in psoriatic arthritis
    Christopher T. Ritchlin
    Current Rheumatology Reports, 2008, 10 (4) : 295 - 296
12345